Biotech Values

[Whalatane]

Dew ..To less then $1,000 a yr ?

Most patients with an insurance covering Vascepa pay less then $1,000 a year for the drug .
Vascepa lower hsCRP by around 20% when combined with most Statins , and even more with high intensity Statins .
Llaris will only be prescribe for hsCRP's >2 ...so expect optimal doses of high intensity Statins combined with Vascepa before any one pays for ( or prescribes ) Liaris .

Crestor ( considered by many to be the strongest Statin ) is now generic , Vascepa for less then $100 a month for most with insurance coverage.....Laris will be a tough sell unless their RRR is huge

JMO as a CAD patient
Kiwi